(Q36292940)

13 August 2017

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder? (English)

1 reference

transitional cell carcinoma

13 August 2017

1 reference

Bartlett JM

1

1 reference

13 August 2017

Watters AD

2

1 reference

13 August 2017

Ballantyne SA

3

1 reference

13 August 2017

Going JJ

4

1 reference

13 August 2017

Grigor KM

5

1 reference

13 August 2017

Cooke TG

6

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Cancer

13 August 2017

1 reference

13 August 2017

77

1 reference

13 August 2017

12

1 reference

13 August 2017

2193-2198

1 reference

A molecular genetic model of human bladder cancer pathogenesis

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

C-erbB-2 gene amplification: a molecular marker in recurrent bladder tumors?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

Bladder and kidney cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

Chromosome changes in early bladder neoplasms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

A model for evaluation of in situ hybridization spot‐count distributions in tissue sections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

Role of chromosome 9 in human bladder cancer.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150395

Heterogeneity in bladder cancer as detected by conventional chromosome analysis and interphase cytogenetics

22 September 2018

1 reference

12 December 2020

Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay

1 reference

12 December 2020

Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2cM of IFNA

1 reference

12 December 2020

Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization

1 reference

12 December 2020

Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer

1 reference

12 December 2020

Interphase cytogenetic analysis of erbB2 and topoII alpha co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.365

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference

13 August 2017

PubMed publication ID

9649132

1 reference